Search Results 8831-8840 of 42450 for oral
Direct-Acting Oral Anticoagulants (DOACS) are permitted. Patient is currently receiving or has received systemic corticosteroids ≤ 2 weeks prior to ...
This study is to investigate the clinical usefulness of Gleolan (aminolevulinic acid hydrochloride, 5-ALA), an oral agent for the detection and visualization of ...
... Oral and throat cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Thyroid cancer, Skin lesion, Laryngeal cancer, Salivary gland tumor, Salivary ...
Patients receiving oral anticoagulants, as well as those with an acquired or congenital coagulopathy, are at increased risk for ICH and hemorrhagic ...
* Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...
In addition, oral corticosteroid treatment significantly alters the frequency and function of Breg subsets, which could lead altered clinical outcomes. Aims ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
The purpose of this study is to evaluate the performance of the wearable tPatch device when compared to an oral temperature measuring device in patients who ...
Excellent written and oral communication skills. Non-U.S. citizen applicants. Admission to Mayo Clinic School of Health Sciences is open to U.S. workers in ...
... oral, implanted, or injectable contraceptive hormones or mechanical products such as intrauterine device or barrier methods (diaphragm, condoms, spermicides) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.